163 related articles for article (PubMed ID: 8938275)
21. Toxicity associated with the formation and clearance of immune complexes between antitumour monoclonal antibodies and syngeneic anti-idiotypic antibodies in mice.
Pimm MV; Gribben SJ
J Cancer Res Clin Oncol; 1992; 119(1):41-5. PubMed ID: 1400564
[TBL] [Abstract][Full Text] [Related]
22. Mimicry of the Hodgkin-associated IRAC antigen by an anti-idiotype network: potential use in active immunotherapy of Hodgkin's lymphoma.
Schobert I; Renner C; Pfreundschuh M; Diehl V; Pohl C
Leuk Lymphoma; 1994 May; 13(5-6):429-40. PubMed ID: 8069188
[TBL] [Abstract][Full Text] [Related]
23. [Preparation and characterization of monoclonal anti-anti-idiotypic antibody (3D12) of epithelial ovarian carcinoma].
Zhang C; Cui H; Li Xp; Ye X; Fu Ty; Feng J; Chang Xh; Wei LH
Beijing Da Xue Xue Bao Yi Xue Ban; 2008 Apr; 40(2):170-3. PubMed ID: 18458693
[TBL] [Abstract][Full Text] [Related]
24. Epitope- and antigen-specific cancer vaccines.
Herlyn D; Linnenbach A; Koprowski H; Herlyn M
Int Rev Immunol; 1991; 7(4):245-57. PubMed ID: 1779173
[TBL] [Abstract][Full Text] [Related]
25. A vaccine against Semliki Forest virus consisting of a monoclonal anti-idiotypic antibody cross-linked to a protein which contains virus-specific T-helper cell epitopes.
Kraaijeveld CA; Oosterlaken TA; Snijders A; Benaissa-Trouw BJ; Ekstijn GL; Snippe H
Antiviral Res; 1992 Oct; 19(4):275-84. PubMed ID: 1281391
[TBL] [Abstract][Full Text] [Related]
26. Towards an idiotype vaccine against mammary tumors. Induction of an immune response to breast cancer-associated antigens by anti-idiotypic antibodies.
Smorodinsky NI; Ghendler Y; Bakimer R; Chaitchuk S; Keydar I; Shoenfeld Y
Eur J Immunol; 1988 Nov; 18(11):1713-8. PubMed ID: 2849550
[TBL] [Abstract][Full Text] [Related]
27. Influence of syngeneic monoclonal anti-idiotypic antibodies to murine monoclonal antibodies against tumour-associated antigens on the biodistribution of their target antibodies and their fragments.
Pimm MV; Demignot S; Gribben SJ
J Cancer Res Clin Oncol; 1993; 119(7):408-14. PubMed ID: 8491761
[TBL] [Abstract][Full Text] [Related]
28. Modulation by adjuvants and carriers of the immunogenicity in xenogeneic hosts of mouse anti-idiotypic monoclonal antibody MK2-23, an internal image of human high molecular weight-melanoma associated antigen.
Chen ZJ; Yang H; Liu CC; Hirai S; Ferrone S
Cancer Res; 1993 Jan; 53(1):112-9. PubMed ID: 8416734
[TBL] [Abstract][Full Text] [Related]
29. Colon cancer antigen and anti-idiotype vaccines.
Herlyn D; Birebent B; Akis N; Purev E; Somasundaram R; Mitchell E; Maguire H; Staib L; Mastrangelo M
Cancer Chemother Biol Response Modif; 2003; 21():287-98. PubMed ID: 15338751
[No Abstract] [Full Text] [Related]
30. Human high molecular weight-melanoma associated antigen mimicry by mouse anti-idiotypic monoclonal antibody MK2-23: modulation of the immunogenicity in patients with malignant melanoma.
Mittelman A; Chen GZ; Wong GY; Liu C; Hirai S; Ferrone S
Clin Cancer Res; 1995 Jul; 1(7):705-13. PubMed ID: 9816036
[TBL] [Abstract][Full Text] [Related]
31. A genetic approach to idiotypic vaccination for B cell lymphoma.
Stevenson FK; Zhu D; King CA; Ashworth LJ; Kumar S; Thompsett A; Hawkins RE
Ann N Y Acad Sci; 1995 Nov; 772():212-26. PubMed ID: 8546396
[TBL] [Abstract][Full Text] [Related]
32. Construction and expression of a single chain antibody mimicing human ovarian cancer antigen CA125.
Li AD; Li Z; Wang YH; Zhang YM; Ma J
Cell Mol Immunol; 2006 Feb; 3(1):59-62. PubMed ID: 16549051
[TBL] [Abstract][Full Text] [Related]
33. [Antigen mimicry of anti-idiotypic antibodies for human ovarian carcinoma antigen: generation and characterization of anti anti-idiotype antibodies].
Lu WY; Qian HN
Zhonghua Yi Xue Za Zhi; 1993 Oct; 73(10):581-3, 636. PubMed ID: 7508814
[TBL] [Abstract][Full Text] [Related]
34. Human high molecular weight-melanoma associated antigen mimicry by an anti-idiotypic antibody: characterization of the immunogenicity and the immune response to the mouse monoclonal antibody IMel-1.
Chattopadhyay P; Kaveri SV; Byars N; Starkey J; Ferrone S; Raychaudhuri S
Cancer Res; 1991 Nov; 51(22):6045-51. PubMed ID: 1933867
[TBL] [Abstract][Full Text] [Related]
35. Active specific immunotherapy of malignant melanoma with anti-idiotypic monoclonal antibodies.
Ferrone S; Kageshita T; Hirai S
J Dermatol; 1993 Sep; 20(9):533-9. PubMed ID: 8227707
[TBL] [Abstract][Full Text] [Related]
36. Murine monoclonal anti-idiotypic antibody as a surrogate antigen for human Her-2/neu.
Baral R; Sherrat A; Das R; Foon KA; Bhattacharya-Chatterjee M
Int J Cancer; 2001 Apr; 92(1):88-95. PubMed ID: 11279611
[TBL] [Abstract][Full Text] [Related]
37. Idiotypic cascades after injection of the monoclonal antibody OC125: a study in a mouse model. Induction of antibodies against OC125 and CA125 after immunization with an anti-CA 125 (MAb OC125) monoclonal antibody by activation of the idiotypic network.
Schultes BC; Reinsberg J; Schlebusch H; Oehr P; Biersack HJ; Krebs D; Wagner U
Eur J Clin Chem Clin Biochem; 1993 Jul; 31(7):427-32. PubMed ID: 8399782
[TBL] [Abstract][Full Text] [Related]
38. Human high molecular weight-melanoma associated antigen mimicry by mouse anti-idiotypic monoclonal antibodies MK2-23. Experimental studies and clinical trials in patients with malignant melanoma.
Ferrone S; Chen ZJ; Liu CC; Hirai S; Kageshita T; Mittelman A
Pharmacol Ther; 1993; 57(2-3):259-90. PubMed ID: 8361995
[TBL] [Abstract][Full Text] [Related]
39. Monoclonal anti-idiotype antibody bearing the internal image of nasopharyngeal carcinoma associated antigen.
Li G; Hu J; Zhou G; Zhu J; Sun Q
Chin Med J (Engl); 2001 Sep; 114(9):962-6. PubMed ID: 11780392
[TBL] [Abstract][Full Text] [Related]
40. Immunochemical and functional characterization of anti-idiotypic antibodies to a mouse anti-CD4 monoclonal antibody.
Perosa F; Dannecker G; Ferrone S; Dammacco F
Int J Clin Lab Res; 1991; 21(2):179-85. PubMed ID: 1815763
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
